 - Men who are sexually active with WOCBP must use any contraceptive method with a failure rate of less than 1 per year Men receiving nivolumab wwo ipilimumab and who are sexually active with WOCBP will be instructed to adhere to contraception for a period of 31 weeks after the last dose of investigational product. 